Virtus ETF Advisers LLC Xenon Pharmaceuticals Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,425 shares of XENE stock, worth $92,901. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,425

Previous 2,380 1.89%

Holding current value

$92,901

Previous $92,000 3.26%

% of portfolio

0.05%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $1,625 - $1,978	45 Added 1.89%	2,425 $95,000
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $10,041 - $12,118	277 Added 13.17%	2,380 $92,000
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $6,057 - $7,105	-142 Reduced 6.33%	2,103 $90,000
Q4 2023 Feb 15, 2024	SELL	$28.7 - $46.46 $2,267 - $3,670	-79 Reduced 3.4%	2,245 $103,000
Q3 2023 Nov 07, 2023	SELL	$34.16 - $39.73 $7,788 - $9,058	-228 Reduced 8.93%	2,324 $79,000
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $2,020 - $2,525	-58 Reduced 2.22%	2,552 $98,000
Q1 2023 May 15, 2023	SELL	$33.46 - $40.35 $33,660 - $40,592	-1,006 Reduced 27.82%	2,610 $93,000
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $1,884 - $2,247	-57 Reduced 1.55%	3,616 $142,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $923 - $1,194	30 Added 0.82%	3,673 $133,000
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $61,946 - $85,614	-2,435 Reduced 40.06%	3,643 $111,000
Q1 2022 May 16, 2022	SELL	$25.09 - $33.13 $9,057 - $11,959	-361 Reduced 5.61%	6,078 $186,000
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $78,858 - $178,947	-5,055 Reduced 43.98%	6,439 $201,000
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $8,871 - $11,611	-597 Reduced 4.94%	11,494 $176,000
Q2 2021 Aug 10, 2021	SELL	$16.81 - $20.0 $213,957 - $254,560	-12,728 Reduced 51.28%	12,091 $225,000
Q1 2021 May 17, 2021	BUY	$13.65 - $21.31 $5,978 - $9,333	438 Added 1.8%	24,819 $444,000
Q4 2020 Feb 12, 2021	SELL	$9.49 - $16.04 $12,261 - $20,723	-1,292 Reduced 5.03%	24,381 $375,000
Q3 2020 Nov 13, 2020	SELL	$10.82 - $13.35 $37,837 - $46,684	-3,497 Reduced 11.99%	25,673 $284,000
Q2 2020 Aug 05, 2020	BUY	$10.21 - $14.9 $297,825 - $434,633	29,170 New	29,170 $366,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Xenon Pharmaceuticals Inc. Transaction History